Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293724773> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W4293724773 endingPage "1397" @default.
- W4293724773 startingPage "1397" @default.
- W4293724773 abstract "The present study evaluates the adverse effects of three vaccines: AstraZeneca (Vaxzevria), Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) according to the dose. From 733 participants collected, the vaccine schedule was as follows: 330 (45%) received a double dose of the AstraZeneca vaccine, 382 (52.1%) received a double dose of Pfizer, 18 (2.5%) received a heterologous prime boost and 3 (0.4%) received a single dose. Pfizer and Moderna vaccines were administered as a third dose in 70 and 121 individuals, respectively. Local and systemic reactions observed in the three vaccines were mild to moderate in severity. Only one AstraZeneca recipient (0.3%) presented a serious adverse effect: blurred vision. Adverse events were more frequent after the first dose of AstraZeneca and after the second dose of Pfizer. As the third dose, Moderna causes more adverse effects than Pfizer regardless of the type of vaccine previously administered, whereas the reactogenicity of a third dose of Pfizer is slightly higher in the group previously vaccinated with Pfizer than in that group with AstraZeneca. In short, secondary effects of the third dose of COVID-19 vaccines were similar to those after dose 2, but their frequency depends on the type of vaccine and the combinations of vaccines." @default.
- W4293724773 created "2022-08-31" @default.
- W4293724773 creator A5015556921 @default.
- W4293724773 creator A5022370339 @default.
- W4293724773 creator A5041412658 @default.
- W4293724773 creator A5044252481 @default.
- W4293724773 creator A5074873172 @default.
- W4293724773 creator A5076663223 @default.
- W4293724773 creator A5086310187 @default.
- W4293724773 creator A5018884577 @default.
- W4293724773 date "2022-08-25" @default.
- W4293724773 modified "2023-09-30" @default.
- W4293724773 title "Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose" @default.
- W4293724773 cites W3111255098 @default.
- W4293724773 cites W3129250309 @default.
- W4293724773 cites W3158373340 @default.
- W4293724773 cites W3178846646 @default.
- W4293724773 cites W3180936776 @default.
- W4293724773 cites W3196028820 @default.
- W4293724773 cites W3202964367 @default.
- W4293724773 cites W4200049649 @default.
- W4293724773 cites W4207017024 @default.
- W4293724773 cites W4225711802 @default.
- W4293724773 cites W4226019128 @default.
- W4293724773 doi "https://doi.org/10.3390/vaccines10091397" @default.
- W4293724773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36146475" @default.
- W4293724773 hasPublicationYear "2022" @default.
- W4293724773 type Work @default.
- W4293724773 citedByCount "4" @default.
- W4293724773 countsByYear W42937247732023 @default.
- W4293724773 crossrefType "journal-article" @default.
- W4293724773 hasAuthorship W4293724773A5015556921 @default.
- W4293724773 hasAuthorship W4293724773A5018884577 @default.
- W4293724773 hasAuthorship W4293724773A5022370339 @default.
- W4293724773 hasAuthorship W4293724773A5041412658 @default.
- W4293724773 hasAuthorship W4293724773A5044252481 @default.
- W4293724773 hasAuthorship W4293724773A5074873172 @default.
- W4293724773 hasAuthorship W4293724773A5076663223 @default.
- W4293724773 hasAuthorship W4293724773A5086310187 @default.
- W4293724773 hasBestOaLocation W42937247731 @default.
- W4293724773 hasConcept C121332964 @default.
- W4293724773 hasConcept C12590561 @default.
- W4293724773 hasConcept C126322002 @default.
- W4293724773 hasConcept C1276947 @default.
- W4293724773 hasConcept C197934379 @default.
- W4293724773 hasConcept C203014093 @default.
- W4293724773 hasConcept C203165030 @default.
- W4293724773 hasConcept C2777704310 @default.
- W4293724773 hasConcept C2779134260 @default.
- W4293724773 hasConcept C2780801004 @default.
- W4293724773 hasConcept C3008058167 @default.
- W4293724773 hasConcept C524204448 @default.
- W4293724773 hasConcept C71924100 @default.
- W4293724773 hasConcept C8891405 @default.
- W4293724773 hasConceptScore W4293724773C121332964 @default.
- W4293724773 hasConceptScore W4293724773C12590561 @default.
- W4293724773 hasConceptScore W4293724773C126322002 @default.
- W4293724773 hasConceptScore W4293724773C1276947 @default.
- W4293724773 hasConceptScore W4293724773C197934379 @default.
- W4293724773 hasConceptScore W4293724773C203014093 @default.
- W4293724773 hasConceptScore W4293724773C203165030 @default.
- W4293724773 hasConceptScore W4293724773C2777704310 @default.
- W4293724773 hasConceptScore W4293724773C2779134260 @default.
- W4293724773 hasConceptScore W4293724773C2780801004 @default.
- W4293724773 hasConceptScore W4293724773C3008058167 @default.
- W4293724773 hasConceptScore W4293724773C524204448 @default.
- W4293724773 hasConceptScore W4293724773C71924100 @default.
- W4293724773 hasConceptScore W4293724773C8891405 @default.
- W4293724773 hasIssue "9" @default.
- W4293724773 hasLocation W42937247731 @default.
- W4293724773 hasLocation W42937247732 @default.
- W4293724773 hasLocation W42937247733 @default.
- W4293724773 hasOpenAccess W4293724773 @default.
- W4293724773 hasPrimaryLocation W42937247731 @default.
- W4293724773 hasRelatedWork W1972949921 @default.
- W4293724773 hasRelatedWork W2022744425 @default.
- W4293724773 hasRelatedWork W3202142813 @default.
- W4293724773 hasRelatedWork W3207962278 @default.
- W4293724773 hasRelatedWork W4283450301 @default.
- W4293724773 hasRelatedWork W4289529931 @default.
- W4293724773 hasRelatedWork W4293724773 @default.
- W4293724773 hasRelatedWork W4317932548 @default.
- W4293724773 hasRelatedWork W4321766608 @default.
- W4293724773 hasRelatedWork W4327740868 @default.
- W4293724773 hasVolume "10" @default.
- W4293724773 isParatext "false" @default.
- W4293724773 isRetracted "false" @default.
- W4293724773 workType "article" @default.